Reported Earnings • Aug 20
Second quarter 2026 earnings released: EPS: CN¥0.099 (vs CN¥0.13 in 2Q 2025) Second quarter 2026 results: EPS: CN¥0.099 (down from CN¥0.13 in 2Q 2025). Revenue: CN¥333.4m (down 12% from 2Q 2025). Net income: CN¥28.6m (down 25% from 2Q 2025). Profit margin: 8.6% (down from 10.0% in 2Q 2025). Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings. Anuncio • Jun 30
Hubei Forbon Technology Co.,Ltd. to Report First Half, 2026 Results on Aug 20, 2026 Hubei Forbon Technology Co.,Ltd. announced that they will report first half, 2026 results on Aug 20, 2026 Board Change • Jun 01
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. 2 highly experienced directors. Non-Independent Director Yingzong Wang was the last director to join the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. Anuncio • May 29
Hubei Forbon Technology Co.,Ltd. Announces Final Cash Dividend on A Shares for the Year 2025, Payable on June 01, 2026 Hubei Forbon Technology Co.,Ltd. announced final cash dividend of CNY 0.60000000 per ten shares (tax included) on A shares for the year 2025. Record date: 29 May 2026. Ex-date: 01 June 2026. Payment date: 01 June 2026. New Risk • May 12
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 29% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (4.4% net profit margin). Reported Earnings • Apr 24
First quarter 2026 earnings released: EPS: CN¥0.092 (vs CN¥0.08 in 1Q 2025) First quarter 2026 results: EPS: CN¥0.092 (up from CN¥0.08 in 1Q 2025). Revenue: CN¥340.8m (up 12% from 1Q 2025). Net income: CN¥26.6m (up 15% from 1Q 2025). Profit margin: 7.8% (up from 7.6% in 1Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has increased by 10% per year, which means it is tracking significantly ahead of earnings growth. Anuncio • Apr 23
Hubei Forbon Technology Co.,Ltd., Annual General Meeting, May 19, 2026 Hubei Forbon Technology Co.,Ltd., Annual General Meeting, May 19, 2026, at 14:30 China Standard Time. Location: No. 288, Shendun 3rd Road, East Lake High-tech Development Zone, Wuhan, Hubei China Anuncio • Mar 31
Hubei Forbon Technology Co.,Ltd. to Report Q1, 2026 Results on Apr 23, 2026 Hubei Forbon Technology Co.,Ltd. announced that they will report Q1, 2026 results on Apr 23, 2026 Valuation Update With 7 Day Price Move • Mar 23
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to CN¥8.43, the stock trades at a trailing P/E ratio of 29.6x. Average trailing P/E is 45x in the Chemicals industry in China. Total returns to shareholders of 19% over the past three years. Anuncio • Dec 31
Hubei Forbon Technology Co.,Ltd. to Report Fiscal Year 2025 Results on Apr 23, 2026 Hubei Forbon Technology Co.,Ltd. announced that they will report fiscal year 2025 results on Apr 23, 2026 Reported Earnings • Oct 26
Third quarter 2025 earnings released: EPS: CN¥0.067 (vs CN¥0.076 in 3Q 2024) Third quarter 2025 results: EPS: CN¥0.067 (down from CN¥0.076 in 3Q 2024). Revenue: CN¥331.7m (up 15% from 3Q 2024). Net income: CN¥19.4m (down 12% from 3Q 2024). Profit margin: 5.9% (down from 7.6% in 3Q 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 21% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 19% per year whereas the company’s share price has increased by 15% per year. Anuncio • Sep 30
Hubei Forbon Technology Co.,Ltd. to Report Q3, 2025 Results on Oct 27, 2025 Hubei Forbon Technology Co.,Ltd. announced that they will report Q3, 2025 results on Oct 27, 2025 Reported Earnings • Aug 24
Second quarter 2025 earnings released: EPS: CN¥0.13 (vs CN¥0.15 in 2Q 2024) Second quarter 2025 results: EPS: CN¥0.13 (down from CN¥0.15 in 2Q 2024). Revenue: CN¥379.7m (up 16% from 2Q 2024). Net income: CN¥38.1m (down 13% from 2Q 2024). Profit margin: 10.0% (down from 13% in 2Q 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 21% p.a. on average during the next 3 years, compared to a 14% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth. Buy Or Sell Opportunity • Aug 21
Now 21% overvalued after recent price rise Over the last 90 days, the stock has risen 20% to CN¥9.90. The fair value is estimated to be CN¥8.19, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 20% over the last 3 years. Earnings per share has grown by 33%. Revenue is forecast to grow by 50% in 2 years. Earnings are forecast to grow by 137% in the next 2 years. Buy Or Sell Opportunity • Jul 28
Now 22% overvalued after recent price rise Over the last 90 days, the stock has risen 21% to CN¥9.86. The fair value is estimated to be CN¥8.07, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 20% over the last 3 years. Earnings per share has grown by 33%. Revenue is forecast to grow by 50% in 2 years. Earnings are forecast to grow by 137% in the next 2 years. Buy Or Sell Opportunity • Jul 09
Now 20% overvalued after recent price rise Over the last 90 days, the stock has risen 6.2% to CN¥9.70. The fair value is estimated to be CN¥8.08, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 20% over the last 3 years. Earnings per share has grown by 33%. Revenue is forecast to grow by 50% in 2 years. Earnings are forecast to grow by 137% in the next 2 years. Anuncio • Jul 02
Hubei Forbon Technology Co.,Ltd. to Report First Half, 2025 Results on Aug 22, 2025 Hubei Forbon Technology Co.,Ltd. announced that they will report first half, 2025 results on Aug 22, 2025 Declared Dividend • May 29
Dividend increased to CN¥0.07 Dividend of CN¥0.07 is 17% higher than last year. Ex-date: 30th May 2025 Payment date: 30th May 2025 Dividend yield will be 0.8%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is well covered by both earnings (23% earnings payout ratio) and cash flows (23% cash payout ratio). The dividend has increased by an average of 5.3% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 139% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Major Estimate Revision • May 02
Consensus EPS estimates increase by 17% The consensus outlook for earnings per share (EPS) in fiscal year 2025 has improved. 2025 revenue forecast increased from CN¥1.33b to CN¥1.43b. EPS estimate increased from CN¥0.46 to CN¥0.54 per share. Net income forecast to grow 85% next year vs 44% growth forecast for Chemicals industry in China. Consensus price target up from CN¥9.12 to CN¥10.80. Share price was steady at CN¥8.16 over the past week. Anuncio • Apr 25
Hubei Forbon Technology Co.,Ltd. Proposes Final Cash Dividend for the Year 2024 Hubei Forbon Technology Co.,Ltd. announced on 23 April 2025 the final profit distribution proposal for 2024 as follows: Cash dividend/10 shares (tax included): CNY0.70000000. Reported Earnings • Apr 24
First quarter 2025 earnings released: EPS: CN¥0.08 (vs CN¥0.091 in 1Q 2024) First quarter 2025 results: EPS: CN¥0.08 (down from CN¥0.091 in 1Q 2024). Revenue: CN¥304.9m (down 3.4% from 1Q 2024). Net income: CN¥23.1m (down 12% from 1Q 2024). Profit margin: 7.6% (down from 8.3% in 1Q 2024). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 14% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth. Anuncio • Apr 23
Hubei Forbon Technology Co.,Ltd., Annual General Meeting, May 15, 2025 Hubei Forbon Technology Co.,Ltd., Annual General Meeting, May 15, 2025, at 14:30 China Standard Time. Location: No. 288, Shendun 3rd Road, East Lake High-tech Development Zone, Wuhan, Hubei China Valuation Update With 7 Day Price Move • Apr 14
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to CN¥8.82, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 8.6% over the past three years. New Risk • Apr 08
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company. Anuncio • Mar 31
Hubei Forbon Technology Co.,Ltd. to Report Q1, 2025 Results on Apr 23, 2025 Hubei Forbon Technology Co.,Ltd. announced that they will report Q1, 2025 results on Apr 23, 2025 New Risk • Jan 12
New major risk - Financial data availability The company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. This is currently the only risk that has been identified for the company. Anuncio • Dec 31
Hubei Forbon Technology Co.,Ltd. to Report Fiscal Year 2024 Results on Apr 23, 2025 Hubei Forbon Technology Co.,Ltd. announced that they will report fiscal year 2024 results on Apr 23, 2025 Valuation Update With 7 Day Price Move • Dec 23
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to CN¥8.21, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 29% over the past three years. Reported Earnings • Oct 30
Third quarter 2024 earnings released: EPS: CN¥0.076 (vs CN¥0.089 in 3Q 2023) Third quarter 2024 results: EPS: CN¥0.076 (down from CN¥0.089 in 3Q 2023). Revenue: CN¥288.0m (up 3.1% from 3Q 2023). Net income: CN¥22.0m (down 14% from 3Q 2023). Profit margin: 7.6% (down from 9.2% in 3Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 39% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth. Anuncio • Sep 30
Hubei Forbon Technology Co.,Ltd. to Report Q3, 2024 Results on Oct 30, 2024 Hubei Forbon Technology Co.,Ltd. announced that they will report Q3, 2024 results on Oct 30, 2024 Valuation Update With 7 Day Price Move • Sep 30
Investor sentiment improves as stock rises 23% After last week's 23% share price gain to CN¥7.96, the stock trades at a trailing P/E ratio of 21.7x. Average trailing P/E is 30x in the Chemicals industry in China. Total returns to shareholders of 31% over the past three years. Reported Earnings • Aug 23
Second quarter 2024 earnings released: EPS: CN¥0.15 (vs CN¥0.058 in 2Q 2023) Second quarter 2024 results: EPS: CN¥0.15 (up from CN¥0.058 in 2Q 2023). Revenue: CN¥327.1m (up 46% from 2Q 2023). Net income: CN¥43.7m (up 163% from 2Q 2023). Profit margin: 13% (up from 7.4% in 2Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings. Anuncio • Jun 29
Hubei Forbon Technology Co.,Ltd. to Report First Half, 2024 Results on Aug 23, 2024 Hubei Forbon Technology Co.,Ltd. announced that they will report first half, 2024 results on Aug 23, 2024 New Risk • Jun 07
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 2.7% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (8.4% average weekly change). Anuncio • May 30
Hubei Forbon Technology Co.,Ltd. Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 31 May 2024 Hubei Forbon Technology Co.,Ltd. announced final cash dividend/10 shares (tax included) of CNY 0.60000000 on A shares for the year 2023. Record date is 30 May 2024. Ex-date is 31 May 2024. Payment date is 31 May 2024. Valuation Update With 7 Day Price Move • May 09
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to CN¥7.76, the stock trades at a trailing P/E ratio of 28.5x. Average trailing P/E is 34x in the Chemicals industry in China. Total returns to shareholders of 28% over the past three years. Anuncio • Apr 20
Hubei Forbon Technology Co.,Ltd., Annual General Meeting, May 15, 2024 Hubei Forbon Technology Co.,Ltd., Annual General Meeting, May 15, 2024, at 14:30 China Standard Time. Location: No. 288, Shendun 3rd Road, East Lake High-tech Development Zone, Wuhan, Hubei China Reported Earnings • Apr 19
Full year 2023 earnings released: EPS: CN¥0.25 (vs CN¥0.19 in FY 2022) Full year 2023 results: EPS: CN¥0.25 (up from CN¥0.19 in FY 2022). Revenue: CN¥1.05b (up 24% from FY 2022). Net income: CN¥71.5m (up 33% from FY 2022). Profit margin: 6.8% (up from 6.4% in FY 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • Apr 16
Investor sentiment deteriorates as stock falls 21% After last week's 21% share price decline to CN¥5.15, the stock trades at a trailing P/E ratio of 21.4x. Average trailing P/E is 28x in the Chemicals industry in China. Total loss to shareholders of 22% over the past three years. Anuncio • Mar 30
Hubei Forbon Technology Co.,Ltd. to Report Q1, 2024 Results on Apr 19, 2024 Hubei Forbon Technology Co.,Ltd. announced that they will report Q1, 2024 results on Apr 19, 2024 New Risk • Feb 08
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 8.1% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (7.8% average weekly change). Valuation Update With 7 Day Price Move • Feb 02
Investor sentiment deteriorates as stock falls 20% After last week's 20% share price decline to CN¥5.75, the stock trades at a trailing P/E ratio of 23.9x. Average trailing P/E is 28x in the Chemicals industry in China. Total loss to shareholders of 14% over the past three years. Anuncio • Dec 30
Hubei Forbon Technology Co.,Ltd. to Report Fiscal Year 2023 Results on Apr 19, 2024 Hubei Forbon Technology Co.,Ltd. announced that they will report fiscal year 2023 results on Apr 19, 2024 Reported Earnings • Oct 27
Third quarter 2023 earnings released: EPS: CN¥0.089 (vs CN¥0.043 in 3Q 2022) Third quarter 2023 results: EPS: CN¥0.089 (up from CN¥0.043 in 3Q 2022). Revenue: CN¥279.3m (up 21% from 3Q 2022). Net income: CN¥25.7m (up 118% from 3Q 2022). Profit margin: 9.2% (up from 5.1% in 3Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings. Anuncio • Sep 30
Hubei Forbon Technology Co.,Ltd. to Report Q3, 2023 Results on Oct 27, 2023 Hubei Forbon Technology Co.,Ltd. announced that they will report Q3, 2023 results on Oct 27, 2023 Reported Earnings • Aug 25
Second quarter 2023 earnings released: EPS: CN¥0.058 (vs CN¥0.054 in 2Q 2022) Second quarter 2023 results: EPS: CN¥0.058. Revenue: CN¥224.2m (up 19% from 2Q 2022). Net income: CN¥16.7m (flat on 2Q 2022). Profit margin: 7.4% (down from 8.9% in 2Q 2022). The decrease in margin was driven by higher expenses. Anuncio • Jun 15
Hubei Forbon Technology Co.,Ltd. Announces Final Dividend on A Shares for the Year 2022, Payable on June 21, 2023 Hubei Forbon Technology Co.,Ltd. announced final cash dividend/10 shares (tax included) of CNY0.50000000 on A shares for the year 2022. Record date is June 20, 2023. Ex-date is May June 21, 2023. Payment date is June 21, 2023. Reported Earnings • Apr 29
First quarter 2023 earnings released: EPS: CN¥0.066 (vs CN¥0.05 in 1Q 2022) First quarter 2023 results: EPS: CN¥0.066 (up from CN¥0.05 in 1Q 2022). Revenue: CN¥247.0m (up 26% from 1Q 2022). Net income: CN¥19.0m (up 41% from 1Q 2022). Profit margin: 7.7% (up from 6.9% in 1Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings. Board Change • Jan 01
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. Independent Director Zubin Li was the last director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. Valuation Update With 7 Day Price Move • Nov 07
Investor sentiment improved over the past week After last week's 17% share price gain to CN¥7.29, the stock trades at a trailing P/E ratio of 47.9x. Average trailing P/E is 28x in the Chemicals industry in China. Total loss to shareholders of 20% over the past three years. Reported Earnings • Oct 28
Third quarter 2022 earnings released: EPS: CN¥0.054 (vs CN¥0.032 in 3Q 2021) Third quarter 2022 results: EPS: CN¥0.054 (up from CN¥0.032 in 3Q 2021). Revenue: CN¥209.4m (up 22% from 3Q 2021). Net income: CN¥15.5m (up 54% from 3Q 2021). Profit margin: 7.4% (up from 5.9% in 3Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has only fallen by 14% per year, which means it has not declined as severely as earnings. Reported Earnings • Aug 26
Second quarter 2022 earnings released: EPS: CN¥0.054 (vs CN¥0.028 in 2Q 2021) Second quarter 2022 results: EPS: CN¥0.054 (up from CN¥0.028 in 2Q 2021). Revenue: CN¥188.6m (up 22% from 2Q 2021). Net income: CN¥16.7m (up 125% from 2Q 2021). Profit margin: 8.9% (up from 4.8% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 29% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings. Anuncio • May 27
Hubei Forbon Technology Co.,Ltd. Announces Cash Dividend, Payable on May 31, 2022 Hubei Forbon Technology Co.,Ltd. announced 2021 final profit distribution plan to be implemented (A shares) as Cash dividend/10 shares (tax included): CNY 0.50000000. Record date as 30 May 2022, ex-date as May 31, 2022 and payment date as May 31, 2022. Anuncio • May 21
Hubei Forbon Technology Co.,Ltd. Approves Final Cash Dividend for the Year 2021 Hubei Forbon Technology Co.,Ltd. announced that at its Annual General Meeting of 2021 on 19 May 2022, approved final Cash dividend/10 shares (tax included) of CNY 0.50000000 for the year 2021. Board Change • Apr 27
High number of new and inexperienced directors There are 3 new directors who have joined the board in the last 3 years. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. Independent Director Zubin Li is the most experienced director on the board, commencing their role in 2019. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model. Anuncio • Apr 21
Hubei Forbon Technology Co.,Ltd. Announces the Profit Distribution Proposal for 2021 Hubei Forbon Technology Co.,Ltd. announced the profit distribution proposal for 2021. The company announced cash dividend/10 shares (tax included) of CNY 0.50000000. Reported Earnings • Apr 20
First quarter 2022 earnings: EPS and revenues miss analyst expectations First quarter 2022 results: EPS: CN¥0.05 (down from CN¥0.08 in 1Q 2021). Revenue: CN¥196.4m (up 6.1% from 1Q 2021). Net income: CN¥13.5m (down 43% from 1Q 2021). Profit margin: 6.9% (down from 13% in 1Q 2021). Revenue missed analyst estimates by 19%. Earnings per share (EPS) also missed analyst estimates by 40%. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings. Valuation Update With 7 Day Price Move • Apr 13
Investor sentiment deteriorated over the past week After last week's 17% share price decline to CN¥9.02, the stock trades at a trailing P/E ratio of 75.2x. Average trailing P/E is 28x in the Chemicals industry in China. Total loss to shareholders of 3.2% over the past three years. Valuation Update With 7 Day Price Move • Mar 18
Investor sentiment deteriorated over the past week After last week's 16% share price decline to CN¥9.11, the stock trades at a trailing P/E ratio of 75.9x. Average trailing P/E is 29x in the Chemicals industry in China. Total returns to shareholders of 23% over the past three years. Valuation Update With 7 Day Price Move • Feb 22
Investor sentiment improved over the past week After last week's 22% share price gain to CN¥9.22, the stock trades at a trailing P/E ratio of 76.9x. Average trailing P/E is 33x in the Chemicals industry in China. Total returns to shareholders of 41% over the past three years. Anuncio • Jan 27
Hubei Forbon Technology Co.,Ltd. (SZSE:300387) singed an Equity Transfer Agreement to acquire a 70% stake in Xiangyu Biotechnology (Yueyang) Co., Ltd. from Hunan Xiangyu Technology Co., Ltd. for CNY 87.5 million. Hubei Forbon Technology Co.,Ltd. (SZSE:300387) singed an Equity Transfer Agreement to acquire a 70% stake in Xiangyu Biotechnology (Yueyang) Co., Ltd. from Hunan Xiangyu Technology Co., Ltd. for CNY 87.5 million on December 10, 2021. The acquisition will be completed in tranches as 35%, 24.5%, 7% and 3.5%. Following completion of second tranche, Xiangyu Biotechnology will become a holding subsidiary of Hubei Forbon Technology. Hubei Forbon Technology completed the acquisition of first tranche of 35% stake in Xiangyu Biotechnology from Hunan Xiangyu Technology on January 24, 2022. Valuation Update With 7 Day Price Move • Jan 21
Investor sentiment improved over the past week After last week's 15% share price gain to CN¥7.83, the stock trades at a trailing P/E ratio of 65.3x. Average trailing P/E is 33x in the Chemicals industry in China. Total returns to shareholders of 29% over the past three years. Reported Earnings • Oct 28
Third quarter 2021 earnings released: EPS CN¥0.032 (vs CN¥0.059 in 3Q 2020) The company reported a poor third quarter result with weaker earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥171.3m (down 3.3% from 3Q 2020). Net income: CN¥10.1m (down 42% from 3Q 2020). Profit margin: 5.9% (down from 9.7% in 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 20% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings. Valuation Update With 7 Day Price Move • Sep 29
Investor sentiment deteriorated over the past week After last week's 23% share price decline to CN¥6.17, the stock trades at a trailing P/E ratio of 42.8x. Average trailing P/E is 31x in the Chemicals industry in China. Negligible returns to shareholders over past three years. Reported Earnings • Aug 29
Second quarter 2021 earnings released: EPS CN¥0.028 (vs CN¥0.058 in 2Q 2020) The company reported a soft second quarter result with weaker earnings and profit margins, although revenues improved. Second quarter 2021 results: Revenue: CN¥154.6m (up 5.8% from 2Q 2020). Net income: CN¥7.44m (down 56% from 2Q 2020). Profit margin: 4.8% (down from 11% in 2Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has increased by 6% per year, which means it is well ahead of earnings. Anuncio • May 27
Hubei Forbon Technology Co.,Ltd. Announces 2020 Final Distribution Plan to Be Implemented (A Shares), Payment Date on 01 June 2021 Hubei Forbon Technology Co.,Ltd. announced 2020 final distribution plan to be implemented (A shares). The company announced Cash dividend per 10 shares (tax included) is CNY 0.50000000. Record date of 31 May 2021; Ex-date of 01 June 2021; Payment date on 01 June 2021. Anuncio • May 21
Hubei Forbon Technology Co.,Ltd. Approves Cash Dividend for the Year 2020 Hubei Forbon Technology Co.,Ltd. in its Annual General Meeting of 2020 on 19 May 2021 has approved cash dividend/10 shares (tax included): CNY 0.50000000 for the year 2020. Anuncio • Apr 29
Hubei Forbon Technology Co.,Ltd. Proposes Final Cash Dividend for the Year 2020 Hubei Forbon Technology Co.,Ltd. proposed final cash dividend/10 shares (tax included): CNY 0.50000000 for the year 2020. Reported Earnings • Apr 28
First quarter 2021 earnings released: EPS CN¥0.08 (vs CN¥0.14 in 1Q 2020) The company reported a poor first quarter result with weaker earnings, revenues and profit margins. First quarter 2021 results: Revenue: CN¥185.2m (down 4.6% from 1Q 2020). Net income: CN¥23.6m (down 43% from 1Q 2020). Profit margin: 13% (down from 21% in 1Q 2020). The decrease in margin was primarily driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 12% per year whereas the company’s share price has fallen by 13% per year. Valuation Update With 7 Day Price Move • Feb 22
Investor sentiment improved over the past week After last week's 18% share price gain to CN¥7.43, the stock is trading at a trailing P/E ratio of 32.1x, up from the previous P/E ratio of 27.2x. This compares to an average P/E of 37x in the Chemicals industry in China. Total return to shareholders over the past three years is a loss of 2.2%. Is New 90 Day High Low • Feb 08
New 90-day low: CN¥6.47 The company is down 29% from its price of CN¥9.12 on 10 November 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 12% over the same period. Valuation Update With 7 Day Price Move • Jan 20
Investor sentiment improved over the past week After last week's 19% share price gain to CN¥7.88, the stock is trading at a trailing P/E ratio of 34.1x, up from the previous P/E ratio of 28.7x. This compares to an average P/E of 37x in the Chemicals industry in China. Total return to shareholders over the past three years is a loss of 8.8%. Valuation Update With 7 Day Price Move • Jan 13
Investor sentiment deteriorated over the past week After last week's 15% share price decline to CN¥6.63, the stock is trading at a trailing P/E ratio of 28.7x, down from the previous P/E ratio of 33.9x. This compares to an average P/E of 34x in the Chemicals industry in China. Total return to shareholders over the past three years is a loss of 25%. Is New 90 Day High Low • Jan 11
New 90-day low: CN¥7.00 The company is down 29% from its price of CN¥9.86 on 13 October 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 12% over the same period. Is New 90 Day High Low • Dec 24
New 90-day low: CN¥7.28 The company is down 22% from its price of CN¥9.34 on 25 September 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 9.0% over the same period. Is New 90 Day High Low • Dec 08
New 90-day low: CN¥8.10 The company is down 23% from its price of CN¥10.57 on 09 September 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 6.0% over the same period. Is New 90 Day High Low • Nov 13
New 90-day low: CN¥8.68 The company is down 10.0% from its price of CN¥9.69 on 14 August 2020. The Chinese market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 5.0% over the same period. Reported Earnings • Oct 17
Third quarter earnings released Over the last 12 months the company has reported total profits of CN¥67.4m, down 2.5% from the prior year. Total revenue was CN¥602.4m over the last 12 months, up 4.1% from the prior year. Anuncio • Oct 16
Hubei Forbon Technology Co.,Ltd. to Report Q3, 2020 Results on Oct 17, 2020 Hubei Forbon Technology Co.,Ltd. announced that they will report Q3, 2020 results on Oct 17, 2020 Anuncio • Aug 13
Hubei Forbon Technology Co.,Ltd. to Report First Half, 2020 Results on Aug 28, 2020 Hubei Forbon Technology Co.,Ltd. announced that they will report first half, 2020 results on Aug 28, 2020 
